HCA Healthcare ( (HCA) ) has provided an update.
On February 18, 2025, HCA Healthcare’s Board of Directors adopted the 2025 Executive Officer Performance Excellence Program, which offers performance awards to executive officers based on EBITDA and quality metrics. The program aims to incentivize executives to meet specific financial and quality targets, with awards paid in cash. Additionally, Meg G. Crofton announced her retirement from the Board of Directors, effective April 24, 2025.
More about HCA Healthcare
HCA Healthcare, Inc. operates in the healthcare industry, providing a range of healthcare services through its network of hospitals and healthcare facilities. The company focuses on delivering quality care and improving patient outcomes.
YTD Price Performance: 6.27%
Average Trading Volume: 1,504,077
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $78.58B
Learn more about HCA stock on TipRanks’ Stock Analysis page.